Medtronic "Recovering" From 2007 Defibrillator Wire Recall and Eyes Opportunities Worldwide, an Industrial Info News

SUGAR LAND, TX, Sep 29 (MARKET WIRE) --
Researched by Industrial Info Resources (Sugar Land, Texas) -- Medtronic
Incorporated (NYSE:MDT) (Minneapolis, Minnesota), one of the world's
leading suppliers of medical technology, is planning a 9% to 11% growth
over the next five years. One year after recalling Sprint Fidelis cardiac
defibrillator leads, or wires that connect defibrillators to the heart,
because of breakage in October 2007, Medtronic said it's aiming for a 5%
to 7% increase in its cardiovascular rhythm disease management (CRDM)
division for the next five years. Chairman and CEO William Hawkins said
at the UBS Global Life Sciences Conference in New York this week that the
CRDM business is recovering and that it is "moving now in the right
direction."

For details, view the entire article by subscribing to Industrial Info's
Premium Industry News at
http://www.industrialinfo.com/showNews.jsp?newsitemID=139435, or browse
other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) is a marketing information service
specializing in industrial process, energy and financial related markets
with products and services ranging from industry news, analytics,
forecasting, plant and project databases, as well as multimedia services.
For more information send inquiries to pharmabiogroup@industrialinfo.com
or visit us at www.industrialinfo.com.

Related News Articles

Pharma-Bio 3Q08 Construction Update: 15 New Facilities Open Doors to
Potential $1.9 Billion Investment

Healthcare Leader Abbott Laboratories Shows Sustained Growth and Continues
Plans for 3.5 Million-Square-Foot Wisconsin Facility

MannKind Keeps the Faith in Inhaled Insulin with Opening of $114 Million
Production Plant in Connecticut

Contact:
Joe Govreau
713-783-5147

Copyright 2008, Market Wire, All rights reserved.

-0-